GAP43 and Alzheimer disease: In conclusion, our study suggested a significant association between the CSF level of GAP-43 and microstructural WM findings detected by DTI in patients with different ATN groups suggesting CSF concentration of GAP-43 as a reliable predictive of WM damage as well as cognitive decline in patients with AD continuum.